OncoSec Medical (FRA:ONMA) Total Equity : €-5.09 Mil (As of Jan. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Total Equity?

OncoSec Medical's total equity for the quarter that ended in Jan. 2023 was €-5.09 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

OncoSec Medical Total Equity Historical Data

The historical data trend for OncoSec Medical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Total Equity Chart

OncoSec Medical Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Total Equity

Get a 7-Day Free Trial

19.62

21.66

12.07

32.21

6.01

OncoSec Medical Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Total Equity	Get a 7-Day Free Trial															17.52	12.86	6.01	-1.00	-5.09

OncoSec Medical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

OncoSec Medical's Total Equity for the fiscal year that ended in Jul. 2022 is calculated as

Total Equity	=	Total Assets(Q: Jul. 2022 )	-	Total Liabilities(Q: Jul. 2022 )
	=	21.506	-	15.492
	=	6.01

OncoSec Medical's Total Equity for the quarter that ended in Jan. 2023 is calculated as

Total Equity	=	Total Assets(Q: Jan. 2023 )	-	Total Liabilities(Q: Jan. 2023 )
	=	8.232	-	13.324
	=	-5.09

OncoSec Medical Total Equity Related Terms

Thank you for viewing the detailed overview of OncoSec Medical's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSec Medical (FRA:ONMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

ONCSQ:USA

Address

24 North Main Street, Pennington, NJ, USA, 08534

Website

https://www.oncosec.com

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical (FRA:ONMA) Headlines

No Headlines